Indian Pharmacopoeia Commission Launches Seven Nitrosamine Standards

The Indian Pharmacopoeia Commission (IPC), an autonomous body under the Ministry of Health and Family Welfare, launched seven Indian Pharmacopoeia Nitrosamine Impurities Reference Standards on 25 August 2026. The launch took place during the IPC’s first interactive meeting at the Central Drugs Laboratory and Central Cosmetics Laboratory in Kolkata, West Bengal.

Indian Pharmacopoeia Commission

The Indian Pharmacopoeia Commission is the national body responsible for setting standards for drugs in India. It functions under the Ministry of Health and Family Welfare and works on pharmacopoeial standards, reference materials, and quality control for medicines.

Nitrosamine Impurities

Nitrosamines are a class of chemical compounds known for genotoxic and carcinogenic properties. They can form unintentionally during manufacturing, packaging, storage, or through contamination in pharmaceutical products.

Reference Standards Launched

The seven reference standards introduced by the IPC are N-Nitrosodimethylamine (NDMA), N-Nitrosodiethylamine (NDEA), N-Nitrosoethylisopropylamine (NEIPA), N-Nitrosodibutylamine (NDBA), N-Nitrosomethylphenylamine (NMPA), N-Nitrosodiisopropylamine (NDIPA), and N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). Reference standards are used in laboratories to identify, compare, and quantify specific substances in drug samples.

Important Facts for Exams

• The Indian Pharmacopoeia Commission was established as an autonomous body under the Ministry of Health and Family Welfare.
• Central Drugs Laboratory and Central Cosmetics Laboratory are located in Kolkata, West Bengal.
• NDMA and NDEA are among the most widely cited nitrosamine impurities in pharmaceutical regulation.
• Reference standards are essential for analytical testing, quality control, and impurity profiling in medicines.

Drug Safety and Chronic Medicines

Control of nitrosamine impurities is relevant for medicines used in hypertension, gastric disorders, diabetes, and tuberculosis. The IPC meeting was themed “IP 2026: Perspectives, Suggestions & Way Forward” and included industry experts and stakeholders.

Pharmacopoeial Standards

Pharmacopoeial standards define the identity, purity, strength, and quality of medicines. In India, these standards are used in regulatory testing and in the preparation of official drug monographs.